Gene · 54915
Papers3,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YTHDF1-targeting nanoassembly reverses tumoral immune evasion through epigenetics and cell cycle modulation. | J Control Release | 2025 | 40010410 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Midnolin as a Potential Prognostic, Therapeutic, and Immunological Cancer Biomarker. | Biomedicines | 2025 | 40002690 | PubTator, text mining | PubMed |
| A novel mechanism of FTO modulating the progression of endometriosis through mediating the m6A methylation of GEF-H1 in a YTHDF1-dependent manner. | Mol Med | 2025 | 40000966 | PubTator, text mining | PubMed |
| Systematic molecular profiling of non-native N6-substitution effects on m6A binding to the YTH domains of human RNA m6A readers in diabetes. | Biophys Chem | 2025 | 39987708 | PubTator, text mining | PubMed |
| Endurance exercise remodels skeletal muscle by suppressing Ythdf1-mediated myostatin expression. | Cell Death Dis | 2025 | 39948064 | PubTator, text mining | PubMed |
| N6-Methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma. | Clin Transl Med | 2025 | 39924638 | PubTator, text mining | PubMed |
| Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer. | J Exp Clin Cancer Res | 2025 | 39910592 | PubTator, text mining | PubMed |
| YTHDF1 and YTHDC1 m6A reader proteins regulate HTLV-1 tax and hbz activity. | J Virol | 2025 | 39902961 | PubTator, text mining | PubMed |
| USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation. | Nat Commun | 2025 | 39900921 | Swiss-Prot, curated | PubMed |
| Betaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM/m6A/YTHDF1-mediated enhancement on ATG3 stability. | Theranostics | 2025 | 39897540 | PubTator, text mining | PubMed |
| Sprouting sympathetic fibres release CXCL16 and norepinephrine to synergistically mediate sensory neuronal hyperexcitability in a rodent model of neuropathic pain. | Br J Anaesth | 2025 | 39848871 | PubTator, text mining | PubMed |
| YTHDF1 Regulates RELA m6A Modification and Activates the NF-Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer. | Cancer Med | 2025 | 39821576 | PubTator, text mining | PubMed |
| PM2.5 exposure deteriorates Th1/Th2 balance in pediatric asthma by downregulating ALKBH5 and enhancing SRSF1 m6A methylation. | Int J Biometeorol | 2025 | 39747709 | PubTator, text mining | PubMed |
| WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification. | J Cancer | 2025 | 39744575 | PubTator, text mining | PubMed |
| The N6-methyladenosine demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification. | Cardiovasc Res | 2025 | 39658001 | PubTator, text mining | PubMed |
| Comprehensive Analysis of RNA Methylation-Regulated Gene Signature and Immune Infiltration in Ischemia/Reperfusion-Induced Acute Kidney Injury. | Kidney Blood Press Res | 2025 | 39600181 | PubTator, text mining | PubMed |
| METTL3/YTDHF1 Stabilizes CSRP1 mRNA to Regulate Glycolysis and Promote Acute Myeloid Leukemia Progression. | Cell Biochem Biophys | 2025 | 39565517 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. | Cell Signal | 2025 | 39549823 | PubTator, text mining | PubMed |
| From the genome's perspective: Bearing somatic retrotransposition to leverage the regulatory potential of L1 RNAs. | Bioessays | 2025 | 39520370 | PubTator, text mining | PubMed |
| Spatiotemporal protein interactome profiling through condensation-enhanced photocrosslinking. | Nat Chem | 2025 | 39501047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54915/papers?page=13